Molly Fellin Spence of Clarivate discusses the FDA’s efforts towards advancing the development of products for CNS metastases, where effective treatments and clinical trials are …

Drug discovery and development, while usually a role of the pharmaceutical industry, is a long, difficult and expensive process, which can present academic organisations and …

Adam Istas, DIA explores how global regulators are responding to dramatic increases in cell and gene-based products in development. Regulators are working to provide further …

LOINC is an internationally recognized classification system and is often requested in regulatory data submissions to provide context to clinical measurement data such as Labs …

The FDA has been promoting innovative and disruptive approaches towards modernizing drug development and clinical trials, which the industry has been slow to adopt. These …

Dr Balamuralidhara V. et al of the JSS College of Pharmacy present a study which examines the clinical evaluation and post-marketing surveillance requirements of medical …

Orphan drug discovery presents both opportunities and challenges, with research in this space having some of the highest hurdles in medicine. Clinical trial design and …

Eye health and vision has a major impact on the quality of life, and as such the development of products within this area is a …

Adult onset Still’s disease (AOSD) is a rare inflammatory joint disease of unknown aetiology, characterised by arthritis, fevers spiking once or twice a day, salmon-coloured …